B
Boston Scientific
Boston Scientific, we work collaboratively to solve healthcare’s toughest problems by developing solutions that matter most to those suffering from debilitating
About Boston Scientific
Boston Scientific Corporation is a global leader in the development, manufacturing, and marketing of medical devices that are used in a broad range of interventional medical specialties. The company serves healthcare professionals and patients worldwide, focusing on areas such as cardiology, endoscopy, urology, and neuromodulation. Operating in the medical technology market, Boston Scientific's business model revolves around the continuous innovation of medical devices and solutions that address complex health conditions. Revenue is generated through the sale of these devices to hospitals, clinics, and other healthcare facilities. The company also invests heavily in research and development to maintain its competitive edge and expand its product portfolio.
Source: Dealroom company dataAt a glance
- Status
- Listed
- Founded
- 1979
- Headquarters
- Marlborough, United States
- Listing
- IPO 1992
- Employees
- 55,084
- Open positions
- 430
- Dealroom signal
- 84.9/100
- Industry
- Health
- Sector
- Health, Horizon Europe, DT and LS, observatoire healthtech
- Technology
- Hardware, Deep Tech
- Business model
- Manufacturing
- Client focus
- b2b, b2c
- Investment activity
- 86 companies, latest May 2026
- Capital deployed
- $2.8B
- Preferred round
- ACQUISITION
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| POST IPO DEBT✓Debt | Feb 2026 | $11B | — | Undisclosed | ↗ |
| POST IPO DEBT✓Debt | Feb 2024 | $2B | — | Undisclosed | ↗ |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for Boston Scientific is 620K monthly website visits. Boston Scientific's team grew 19.5% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
MirusMarietta, United StatesFocused on the design of innovative solutions for the treatment of spinal and orthopaedic degeneration and deformities
$4.4Bvaluation
PenumbraAlameda, United StatesPenumbra develops clinically beneficial products that help patients suffering from stroke and other neurovascular diseases
$12Bvaluation
Valencia TechnologiesSanta Clarita, United StatesAlencia Technologies is a neuromodulation company transforming the standard of care for bladder dysfunction
$140Mvaluation
Nalu MedicalCarlsbad, United StatesA range of medical devices
$535Mvaluation
SetPoint MedicalSanta Clarita, United StatesDeveloping novel bioelectronic medicine therapies to treat those who suffer from autoimmune diseases such as rheumatoid arthritis, Crohn's Disease and multiple sclerosis
$460Mvaluation
AnumanaCambridge, United StatesDeveloping and delivering ECG algorithms enabling early diagnosis and intervention
$128Mvaluation
SoniVieRosh Haayin, IsraelDeveloping a novel proprietary therapeutic intra-vascular ultrasound system (tivus) to treat a variety of hypertensive disorders, including pulmonary arterial hypertension (pah)
$400Mvaluation
4C medicalMaple Grove, United StatesA medical device company developing a novel minimally invasive solution for the treatment of mitral regurgitation (MR)
$700Mvaluation
Bolt MedicalCarlsbad, United StatesAdvanced intravascular lithotripsy platform addressing calcified cardiovascular disease challenges
→
CortexSanta Clara, United StatesDeveloping an advanced, comprehensive platform for evaluating and treating AFib precisely, simply, and efficiently
$289Mvaluation
Intera OncologyWellesley, United StatesInnovative hepatic artery infusion pumps enhancing survival for colorectal and cholangiocarcinoma patients
→
AblaconWheat Ridge, United StatesProvider of AI-guided atrial fibrillation therapies
$120Mvaluation
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later2 investors entered at this stage
Railpen
Ardevora Asset Management
Other known investors1 additional known investor
Kleiner Perkins
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Boston Scientific on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Boston Scientific’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







